This study demonstrates that PN-1 should be considered as a new player contributing to the altered hemostasis of patients with stable decompensated cirrhosis, playing mostly an antifibrinolytic role, thus keeping fibrinolysis ‘under control’. Here, SERPINE2 is linked to Cirrhosis.